SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

Loading...

Strategic relationships are changing Pharma and CRO skillset says Parexel

By Gareth Macdonald , 07-Jul-2011
Last updated on 07-Jul-2011 at 09:27 GMT

Parexel says strategic partnerships let pharmaceutical companies streamline how they work with contractors and are changing how CROs view outcomes.

Outsourcing-pharma.com spoke with Joshua Schultz, Parexel VP of strategic account leadership at DIA 2011 who explained that strategic deals, like the one the CRO recently signed with Pfizer, differ markedly from simple transactional relationships.

Having governance…function to function, subject matter expert to subject matter expert, therapeutic area to therapeutic area, local regional folks to local regional folks on both sides really drives great communication that allows issues to be identified earlier than in the old world.”

Schultz said the ability to build systems that work specifically with those in place at the partner organisation, the use of convergent SOPs and training programmes all increase the efficiency of the process.

He also said that, as a result of such partnerships, CROs are becoming more engaged in the success of the research the carry out.

Being in a strategic partnership means you need to own your outcome in a far more fundamental way than in the old transactional models,” explained Schultz.

He also suggested the skills CROs need have changed, citing things which were once marginal offering like feasibility assessment, study start up and regulatory strategies as fundamental in strategic partnerships.

Sponsors have had to change to …the teams that oversee the CRO can be slimmer but they have to have different skill sets too,” Schutlz continued, adding that they require people more used to oversight than doing the work directly are a must.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Related products

Consolidation prevalent in industry, says third largest CMO

Consolidation prevalent in industry, says third largest CMO

Brad Carlson

VP Marketing 7 Sales, Aenova

Catalent commits to ADCs by upping its stake in Redwood

Catalent commits to ADCs by upping its stake in Redwood

Aileen Ruff

Global Strategic Marketing Director, Biologics and Sterile Technologies at Catalent...

Kemwell Talks Expansion and Approvals in India and the US

Kemwell Talks Expansion and Approvals in India and the US

Christian Ahlmark

Director of Corporate Development , Kemwell Biopharma

AMRI Exec Discusses 'New Bar' in FDA Enforcement

Following the completion of remediation efforts to deal with an FDA warning letter, Chris...

Happy holidays from William Reed Business Media!

Happy holidays from William Reed Business Media!

The working year is almost done, time to pause from ‘the business’ and embrace...

Aesica says academic partnerships are key for CMOs

Aesica says academic partnerships are key for CMOs

Alan Raymond

Sales & Marketing Director, Aesica Pharmaceuticals

Wockhardt targets CMO space for diversification

Wockhardt targets CMO space for diversification

Tom Salus

Associate Vice President, Business Development - Contract Services, Wockhardt

Kemwell and Boehringer set to finish biologics plant in India

Kemwell and Boehringer set to finish biologics plant in India

Christian Ahlmark

Director of corporate development , Kemwell

Kemwell CEO says environmental efforts are worth the cost

Kemwell CEO says environmental efforts are worth the cost

Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth...

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Will Downie

Senior VP Global Vusiness Development & Marketing, Catalent

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager, AlpVision

Cobra Biologics talks recent fill finish acquisition and future growth plans

Cobra Biologics talks recent fill finish acquisition and future growth plans

Philip Ridley-smith

Business Development & Marketing Manager, Cobra Biologics

Catalent says sharing with industry will not dull competetive edge

Catalent says sharing with industry will not dull competetive edge

Kurt Nielsen and Cornell Stamoran

Various, Catalent

Bend Research hunting new partnerships to boost bioavailability offering

Bend Research hunting new partnerships to boost bioavailability offering

David Lyon and Karen Coppens

Various, Bend Research and Dow

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Andrea Schiefer

VP of European clinical operations and executive director of pharmacovigilance,...

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

Sue Mackay

Research nursing team manager, ResearchNurses.co

Key Industry Events

 

Access all events listing

Our events, Events from partners...